KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bausch Health Companies (BHC) Interest & Investment Income (2016 - 2025)

Bausch Health Companies' Interest & Investment Income history spans 17 years, with the latest figure at $9.0 million for Q4 2025.

  • For Q4 2025, Interest & Investment Income changed 0.0% year-over-year to $9.0 million; the TTM value through Dec 2025 reached $48.0 million, up 45.45%, while the annual FY2025 figure was $48.0 million, 45.45% up from the prior year.
  • Interest & Investment Income for Q4 2025 was $9.0 million at Bausch Health Companies, down from $15.0 million in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $15.0 million in Q3 2025 and bottomed at $1.0 million in Q4 2021.
  • The 5-year median for Interest & Investment Income is $6.5 million (2022), against an average of $6.4 million.
  • The largest annual shift saw Interest & Investment Income plummeted 71.43% in 2021 before it skyrocketed 500.0% in 2022.
  • A 5-year view of Interest & Investment Income shows it stood at $1.0 million in 2021, then surged by 500.0% to $6.0 million in 2022, then increased by 16.67% to $7.0 million in 2023, then rose by 28.57% to $9.0 million in 2024, then changed by 0.0% to $9.0 million in 2025.
  • Per Business Quant, the three most recent readings for BHC's Interest & Investment Income are $9.0 million (Q4 2025), $15.0 million (Q3 2025), and $13.0 million (Q2 2025).